---
schema_version: "secwatch.filing_event.v1"
accession: "0001420720-22-000091"
form_type: "8-K/A"
ticker: "IBIO"
cik: "0001420720"
company_name: "iBio, Inc."
filed_at: "2022-12-07T23:59:59+00:00"
generated_at: "2026-06-21T08:04:13.449135+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CEO Thomas Isett resigns effective immediately; interim office of CEO established

## Summary
- Thomas F. Isett resigned as CEO and Board member effective December 1, 2022, with employment ending December 31, 2022.
- Severance includes 24-month base salary, pro rata target bonus, 24-month target bonus, and up to 18 months COBRA subsidy.
- Robert Lutz (CFO) and Martin Brenner (CSO) will fill the office of the CEO during the search; leadership reports to Chair William Clark.
- Departure was not due to any disagreement with the Company's strategy, operations, or accounting policies.
- Isett will assist with sale of CDMO assets through March 2023 and litigation matters through December 2024.

## SEC filing metadata
- accession: 0001420720-22-000091
- form_type: 8-K/A
- ticker: IBIO
- cik: 0001420720
- company_name: iBio, Inc.
- filed_at: 2022-12-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420720/000142072022000091/0001420720-22-000091-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420720/000142072022000091/ibio-20221201x8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001420720-22-000091
- JSON: https://secwatch.observer/filing/0001420720-22-000091.json
- Plain text: https://secwatch.observer/filing/0001420720-22-000091.txt

## Key facts
- Executive change
  Thomas F. Isett resigned as Chief Executive Officer at iBio, Inc..
  - Action: resigned
  - Role: Chief Executive Officer
  source text: Mr. Thomas F. Isett, the Chief Executive Officer (the “CEO”) of iBio, Inc., (the “Company”) and a member of the Board of Directors (the “Board”), and the Company, agreed for Mr. Isett to resign as a member of the Board and relinquish his duties, rights and obligations as an officer and the CEO of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1420720/000142072022000091/0001420720-22-000091-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.